Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Cancer Research|July 1, 1988
Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patientsA A Forastiere, J F Belliveau, M P Goren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagusA A Forastiere, M B Orringer, C Perez-Tamayo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinomaP G Corn, E I Heath, R Heitmiller, et al.Seminars in Radiation Oncology|April 21, 1999
Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: preliminary results of two pilot trials using paclitaxel and cisplatinW Flood, D J Lee, A Trotti, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 3, 2003
Chemoprevention for Barrett's esophagus trial. Design and outcome measuresE I Heath, M I Canto, T-T Wu, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancerB Burtness, M Gibson, B Egleston, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Phase I and pharmacologic study of topotecan in patients with impaired renal functionS O'Reilly, E K Rowinsky, W Slichenmyer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancerH Shiga, E I Heath, A A Rasmussen, et al.Pageof 8